Onconetix Stock Widgets and Gadgets
| ONCO Stock | USD 0.80 0.29 26.61% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ONCO Onconetix
- Latest Insider Trading
- ONCO 0.8 -0.29
- Low 0.79
- High 1.08
- Volume 256.5 K
- Alpha -2.17
- Beta 1.92
- Return On Equity -17.58
- Return On Asset -0.22
- Operating Margin (3.00) %
- Current Valuation 23.39 M
- Shares Outstanding 8.29 M
- Shares Owned By Insiders 57.93 %
- Shares Owned By Institutions 7.86 %
- Number Of Shares Shorted 21.7 K
- Price To Book 0.31 X
- Price To Sales 6.18 X
- Revenue 58.47 K
- EBITDA (36.71 M)
- Net Income (37.41 M)
- Cash And Equivalents 113.36 K
- Cash Per Share 0.85 X
- Total Debt 9.89 M
- Current Ratio 0.62 X
- Book Value Per Share (64.14) X
- Cash Flow From Operations (13.58 M)
- Short Ratio 0.23 X
- Earnings Per Share (109.20) X
- Target Price 9.0
- Number Of Employees 12
- Beta 3.73
- Market Capitalization 9.04 M
- Total Asset 88.82 M
- Retained Earnings (56.79 M)
- Working Capital (11.35 M)
- Net Asset 88.82 M
- Accumulation Distribution 68887.62
- Daily Balance Of Power (1.00)
- Rate Of Daily Change 0.73
- Day Median Price 0.94
- Day Typical Price 0.89
- Price Action Indicator (0.28)
- Period Momentum Indicator (0.29)
- Relative Strength Index 25.29
Market Snapshot Widget Example
DAX Index Germany | 19,405 0.43 | |
Taiwan Weighted Taiwan | 22,948 0.19 | |
PSI 20 Stock Portugal | 6,439 0.47 | |
CROBEX Croatia | 3,124 0.19 | |
Budapest SE Hungary | 79,472 0.1 | |
IDX 30 Jakarta Indonesia | 458.68 2.23 | |
ISEQ 20 Price Ireland | 1,615 0.28 | |
NYSE Comp USA | 20,220 0.48 | |
Tel Aviv 35 Israel | 2,281 0.93 | |
Coreshares Index Tracker South Afric | 1,100 0.09 | |
IPC MEXICO Mexico | 50,228 0.42 | |
KL Technology Malaysia | 60.32 1.96 | |
IBEX 35 Index Spain | 11,712 0.47 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,543 0.29 | |
SPASX Dividend Opportunities Australia | 1,697 0.26 | |
HNX 30 Vietnam | 471.74 0.81 | |
Bucharest BET-NG Romania | 1,213 0.53 | |
AMS Small Cap Netherlands | 1,188 0.40 | |
Oslo Exchange Mutual Norway | 1,426 0.25 | |
BEL Small Belgium | 8,148 0.53 | |
Basic Materials Brazil | 5,781 0.32 | |
Swiss Leader Price Switzerland | 1,933 0.06 | |
Fondo Mutuo ETF Chile | 1,368 0.41 | |
Athens General Comp Greece | 1,406 0.33 | |
Stock Exchange Of Thailand | 1,443 0.21 | |
PX Prague Stock Czech Repub | 1,697 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,850 1.03 | |
WIG 30 Poland | 2,826 0.44 | |
BIST Electricity Turkey | 493.66 0.85 |
Investing Ideas
In addition to having Onconetix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Onconetix
Compare Onconetix To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Onconetix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Onconetix Stock, please use our How to Invest in Onconetix guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Onconetix. If investors know Onconetix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Onconetix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (109.20) | Revenue Per Share 2.892 | Return On Assets (0.22) | Return On Equity (17.58) |
The market value of Onconetix is measured differently than its book value, which is the value of Onconetix that is recorded on the company's balance sheet. Investors also form their own opinion of Onconetix's value that differs from its market value or its book value, called intrinsic value, which is Onconetix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Onconetix's market value can be influenced by many factors that don't directly affect Onconetix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Onconetix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Onconetix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Onconetix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.